Philip M W Bath
Bath, Philip M.
Bath, Philip M. W.
VIAF ID: 311800026 (Personal)
Permalink: http://viaf.org/viaf/311800026
Preferred Forms
- 100 1 _ ‡a Bath, Philip M.
-
- 100 0 _ ‡a Philip M W Bath
4xx's: Alternate Name Forms (3)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Efficacy of nitric oxide in stroke : a randomized trial : characteristics of patients recruited in Poland | |
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial. | |
Low glomerular filtration rate, recurrent stroke risk, and effect of renin-angiotensin system modulation | |
Low molecular weight heparin versus aspirin for acute ischemic stroke: a systematic review | |
Lowering blood pressure in acute stroke: lessons learnt from the SCAST trial | |
Magnesium for acute stroke | |
Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay | |
Multi-level community interventions for primary stroke prevention: A conceptual approach by the World Stroke Organization | |
National institutes of health stroke scale item profiles as predictor of patient outcome: external validation on independent trial data | |
Need for ethics approval and patient consent in clinical research. | |
The neuronal nitric oxide synthase inhibitor, TRIM, as a neuroprotective agent: effects in models of cerebral ischaemia using histological and magnetic resonance imaging techniques | |
Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain | |
Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. | |
No Association Between Serum Platelet-derived Growth Factor, Platelet Size, and Regression of Angiographically-defined Coronary Artery Disease. | |
Obesity and recurrent vascular risk after a recent ischemic stroke | |
Ordinal reanalysis of the SHEP trial | |
Original articles: increased platelet volume in patients with adult polycystic kidney disease | |
Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials | |
P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist | |
Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. | |
Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions | |
Pharyngeal electrical stimulation for neurogenic dysphagia following stroke, traumatic brain injury or other causes: Main results from the PHADER cohort study | |
Plasma nitric oxide | |
Platelet and Erythrocyte Volume and Count: Epidemiological Predictors of Impedance Measured ADP-Induced Platelet Aggregation in Whole Blood | |
Prevention. European Stroke Initiative | |
Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids. | |
Progesterone for the treatment of experimental brain injury; a systematic review | |
Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. | |
Prothrombotic megakaryocyte and platelet changes in hypertension are reversed following treatment: a pilot study | |
Protocol for a prospective collaborative systematic review and meta-analysis of individual patient data from randomized controlled trials of vasoactive drugs in acute stroke: The Blood pressure in Acute Stroke Collaboration, stage-3 | |
Psychometric assessment and validation of the dysphagia severity rating scale in stroke patients | |
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy | |
Pulse pressure as a predictor of stroke | |
Quadriceps muscle weakness following acute hemiplegic stroke. | |
Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: Protocol | |
Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensi | |
Relationship between therapeutic changes in blood pressure and outcomes in acute stroke: a metaregression. | |
Reliability of the Penetration–Aspiration Scale and Temporal and Clearance Measures in Poststroke Dysphagia: Videofluoroscopic Analysis From the Swallowing Treatment using Electrical Pharyngeal Stimulation Trial | |
Reprint: Good laboratory practice: preventing introduction of bias at the bench. | |
Role of aspirin in MATCH | |
Sample size calculations in acute stroke trials: a systematic review of their reporting, characteristics, and relationship with outcome | |
Should stroke trials adjust functional outcome for baseline prognostic factors? | |
Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology. | |
Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke. | |
Statistical analysis plan for the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial. | |
Stem cells for enhancing recovery after stroke: a review. | |
Stroke outcome in clinical trial patients deriving from different countries | |
Systematic reviews as a tool for planning and interpreting trials | |
Telmisartan to prevent recurrent stroke and cardiovascular events | |
Testing Devices for the Prevention and Treatment of Stroke and its Complications | |
Testing for differential item functioning within the EQ-5D. | |
Thigh-length compression stockings and DVT after stroke | |
THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA. | |
The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST. | |
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial | |
Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461) | |
Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT | |
Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. | |
Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis | |
Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT | |
Types of stroke recurrence in patients with ischemic stroke: a substudy from the PRoFESS trial | |
Use of ordinal outcomes in vascular prevention trials: comparison with binary outcomes in published trials | |
Very low quality of life after acute stroke: data from the Efficacy of Nitric Oxide in Stroke trial | |
Views of paramedics on their role in an out-of-hospital ambulance-based trial in ultra-acute stroke: qualitative data from the Rapid Intervention With Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT). | |
The Virtual International Stroke Trials Archive. | |
Von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome |